About
What is VICH
Role of VICH
VICH Structure
VICH Process
What is the VICH Outreach Forum
Guidelines
General
Biologicals
Pharmaceuticals
Pharmacovigilance
Activities
Dates of next meetings
Dates of next Public conference
Public consultations
Library
Press releases
VICH Statements
VICH Steering Committee Minutes
VICH Outreach Forum minutes
Concept Papers
Procedural Guidance
Organisational documents (Priorities, Strategy and charter)
Conference documents archive
Other Documents
Training
General training material
Module 1 - General Topics
Module 2 - Quality
Module 3 - Efficacy
Module 4 - Safety
Module 5 - Biologicals
Module 6 - Pharmacovigilance
Contact
Members login
Remember me next time
I agree to the
privacy policy
Guidelines
Quality
Analytical validation
Impurities
Stability
Specifications
Safety
Environmental safety
Metabolism and residue kinetics
Toxicology
Target animal safety
Antimicrobial safety
Efficacy
Good clinical practice
Anthelmintics
Bioequivalence
Environmental safety
Environmental Impact Assessment (EIAs) for veterinary medicinal products (VMPs) - Phase 1
VICH GL6 (Ecotoxicity - Phase 1) June 2000 - Implemented in July 2001
Environmental Impact Assessment (EIAs) for Veterinary Medicinal Products (VMPs) - Phase II
VICH GL38 (Ecotoxicity Phase II) October 2004 - Implemented in October 2005